Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-108970·Canaan XII L.P.
Schedule 13G ownership disclosure
CIDARA THERAPEUTICS INC
COMMON STOCK, $0.0001 PAR VALUE PER SHARE · CUSIP: 171757206
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Canaan XII L.P.
Shares: 0 · Class: 0.0%
- Canaan Partners XII LLC
Shares: 0 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-108970
- Form type
- SCHEDULE 13G/A
- Filer
- Canaan XII L.P.
- CIK
- CIK 1809934
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership